New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

BACKGROUND: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ueda, Youki, Takeda, Midori, Mori, Kyoko, Dansako, Hiromichi, Wakita, Takaji, Kim, Hye-Sook, Sato, Akira, Wataya, Yusuke, Ikeda, Masanori, Kato, Nobuyuki
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3758303/
https://ncbi.nlm.nih.gov/pubmed/24023620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072519
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires